​

Funding Round

Series C - Frequency Therapeutics

Series C - Frequency Therapeutics

Investment Firm

Overview

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Announced Date

Jul 23, 2019

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

8

Investor Name
Participant InvestorRivas Capital
Participant InvestorCobro Ventures
Participant InvestorPerceptive Advisors
Participant InvestorRTW Investments
Participant InvestorTaiwania Capital Management Corporation

Round Details and Background

Frequency Therapeutics raised an undisclosed amount on 2019-07-23 in Series C

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 17, 2020
Post-IPO Equity - Frequency Therapeutics
7-42.3M
Jul 07, 2017
Series B - Frequency Therapeutics
1-undefined
Aug 15, 2022
Post-IPO Equity - Frequency Therapeutics
1-undefined
Apr 11, 2017
Series A - Frequency Therapeutics
7-32.0M

Recent Activity

There is no recent news or activity for this profile.